EDAP’s Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer

EDAP’s Ablatherm-HIFU Offers Reliable Therapy for Localized Prostate Cancer

[at noodls] – LYON, France, Feb. 22, 2013 (GLOBE NEWSWIRE) — EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today new long term data demonstrating high rates of both cancer-specific … more

View todays social media effects on EDAP

View the latest stocks trending across Twitter. Click to view dashboard

See who EDAP is hiring next, click here to view

Share this post